These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 352949)

  • 1. Isolation and characterization of a Streptococcus mutans bacteriocin inhibitor from Streptococcus pyogenes.
    Perry D; Slade HD
    Infect Immun; 1978 May; 20(2):578-80. PubMed ID: 352949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and properties of an extracellular bacteriocin from Streptococcus mutans bacteriocidal for group A and other streptococci.
    Paul D; Slade HD
    Infect Immun; 1975 Dec; 12(6):1375-85. PubMed ID: 1107225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational loss of sensitivity to mutacin GS-5 in Streptococcus pyogenes: characterization of a mutant deficient in receptor protein.
    Franker CK
    Antimicrob Agents Chemother; 1980 Feb; 17(2):151-6. PubMed ID: 6992710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mutacin administration on Streptococcus mutans-induced dental caries in rats.
    Ooshima T; Yasufuku Y; Izumitani A; Sumi N; Iwanami T
    Microbiol Immunol; 1985; 29(12):1163-73. PubMed ID: 3831717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii.
    Wang BY; Kuramitsu HK
    Appl Environ Microbiol; 2005 Jan; 71(1):354-62. PubMed ID: 15640209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of mutacin b, an antibacterial substance produced by Streptococcus mutans strain BHT.
    Delisle AL
    Microbios; 1986; 46(186):21-8. PubMed ID: 3526096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational loss of susceptibility to mutacin GS-5 in Streptococcus pyogenes: surface protein in a tolerant variant.
    Franker CK
    Antimicrob Agents Chemother; 1981 Jan; 19(1):166-9. PubMed ID: 7018382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and characteristics of surface proteins from Streptococcus group A].
    Savel'ev EP; Blinnikova EI; Bitko SA; Degtiareva OP
    Biokhimiia; 1987 Nov; 52(11):1875-80. PubMed ID: 3326638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriocin of a group A streptococcus: partial purification and properties.
    Tagg JR; Read RS; McGiven AR
    Antimicrob Agents Chemother; 1973 Sep; 4(3):214-21. PubMed ID: 4586138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of inhibitory action of a bacteriocin produced by Streptococcus mutans C3603.
    Takada K; Ikeda T; Mitsui I; Shiota T
    Infect Immun; 1984 May; 44(2):370-8. PubMed ID: 6715039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M protein of type 12 Strepto coccus pyogenes. Isolation by electrofocusing and some molecular weight-dependent properties.
    Havlícek J
    Pathol Microbiol (Basel); 1975; 42(3):147-58. PubMed ID: 810761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and certain properties of a bacteriocin from Streptococcus mutans.
    Ikeda T; Iwanami T; Hirasawa M; Watanabe C; McGhee JR; Shiota T
    Infect Immun; 1982 Mar; 35(3):861-8. PubMed ID: 7068219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of leukocyte chemotactic activity of bacteriocin from Streptococcus mutans Rm-10.
    Tsukamoto Y; Fukutani S; Takayama Y; Fukushima H; Sagawa H; Mori M
    Inflammation; 1990 Oct; 14(5):561-9. PubMed ID: 2249887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M-type 57 group A streptococcus bacteriocin.
    Simpson WJ; Tagg JR
    Can J Microbiol; 1983 Oct; 29(10):1445-51. PubMed ID: 6362811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracoagulation of fibrinogen in vitro and in vivo by protein T of Steptococcus pyogenes.
    Ludwicka A; Jeljaszewicz J
    Zentralbl Bakteriol Orig A; 1978 Sep; 241(3):301-7. PubMed ID: 364884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a Streptococcus mutans strain producing a novel bacteriocin.
    Hillman JD; Johnson KP; Yaphe BI
    Infect Immun; 1984 Apr; 44(1):141-4. PubMed ID: 6706403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trial in isolation of native M protein from the cell wall of Streptococcus type A].
    Naniwa K; Kato K; Kotani S
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):88. PubMed ID: 765573
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and mode of action of a cell-free bacteriocin (mutacin) from serotype g Streptococcus mutans MT3791.
    Hamada S; Imanishi H; Ooshima T
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 May; 261(3):287-98. PubMed ID: 3739462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriocin production and susceptibility among strains of Streptococcus mutans grown in the presence of sucrose.
    Rogers AH
    Antimicrob Agents Chemother; 1974 Nov; 6(5):547-50. PubMed ID: 15825303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of bacteriocins in a liquid medium by Streptococcus mutans.
    Delisle AL
    Antimicrob Agents Chemother; 1975 Dec; 8(6):707-12. PubMed ID: 1211924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.